AG2R La Mondiale Gestion d'Actifs’s Alnylam Pharmaceuticals ALNY Stock Holding History

AG2R La Mondiale Gestion d'Actifs’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.96M	Buy	6,512 +307	+5%	+$92.6K	0.07%	250
2026 Q1	$2.05M	Buy	6,205 +610	+11%	+$208K	0.09%	207
2025 Q4	$2.22M	Sell	5,595 -230	-4%	-$102K	0.1%	184
2025 Q3	$1.9M	Hold	5,825	–	–	0.1%	196
2025 Q2	$1.9M	Hold	5,825	–	–	0.1%	196
2025 Q1	$1.77M	Buy	+5,825	New	+$1.5M	0.1%	205

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AG2R La Mondiale Gestion d'Actifs's ALNY Position: Q2 2026 in Review

AG2R La Mondiale Gestion d'Actifs increased its Alnylam Pharmaceuticals (ALNY) stake by 4.9% in Q2 2026, buying an estimated $92.6K and bringing the position to 6,512 shares worth $1.96M. The position accounts for 0.07% of the portfolio, ranked #250.

AG2R La Mondiale Gestion d'Actifs first reported a position in ALNY in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.22M in Q4 2025. 785 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

AG2R La Mondiale Gestion d'Actifs held 6,512 shares of Alnylam Pharmaceuticals worth $1.96M as of Q2 2026.
AG2R La Mondiale Gestion d'Actifs bought 307 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $92.6K.
Alnylam Pharmaceuticals made up 0.07% of AG2R La Mondiale Gestion d'Actifs's portfolio in Q2 2026, its #250 holding.
AG2R La Mondiale Gestion d'Actifs first reported a position in Alnylam Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
AG2R La Mondiale Gestion d'Actifs's Alnylam Pharmaceuticals position peaked at $2.22M in Q4 2025.
785 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on AG2R La Mondiale Gestion d'Actifs's 13F filing for Q2 2026, filed 23 Jul 2026.